Gerrit DeBoer

发表

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of respon

John M.L. Ebos, Mark Clemons, Robert Buckman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

Ellen Warner, Martin J Yaffe, Donald B Plewes, 2004, JAMA.

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Neil Fleshner, L. Klotz, N. Fleshner, 2002, The Journal of urology.